Yttrium-90 Radioembolization for High-Risk Hepatocellular Adenomas: A Single-Institution Experience.
PURPOSE To evaluate the safety and efficacy of Yttrium-90 (Y-90) transarterial radioembolization (TARE) for the treatment of high-risk hepatocellular adenomas (HCAs) at a single tertiary care center. MATERIALS AND METHODS A retrospective review was performed of all patients who underwent TARE for HCAs at a tertiary c...